NLS Pharmaceutics Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -1.39%43.850.9%$1523.47m
ABBVAbbVie, Inc. -0.39%107.661.9%$991.05m
JNJJohnson & Johnson -0.36%164.620.7%$987.18m
MRKMerck & Co., Inc. -0.50%71.610.7%$796.28m
LLYEli Lilly & Co. -0.47%229.961.1%$594.20m
BMYBristol-Myers Squibb Co. 0.03%61.251.0%$551.71m
AZNAstraZeneca Plc -1.84%55.561.0%$261.07m
NVSNovartis AG -1.08%83.470.2%$168.99m
SNYSanofi 0.39%48.380.2%$137.69m
GSKGlaxoSmithKline Plc -0.44%38.940.2%$122.91m
RPRXRoyalty Pharma Plc 0.31%38.500.1%$119.08m
NVONovo Nordisk A/S -0.94%101.420.1%$109.34m
VTRSViatris, Inc. -0.88%13.570.0%$109.22m
RGENRepligen Corp. 2.34%306.906.8%$102.98m
APLSApellis Pharmaceuticals, Inc. 0.62%34.210.0%$96.93m

Company Profile

NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder(ADHD). The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.